HealthEquity
238 hedge funds and large institutions have $3.03B invested in HealthEquity in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 98 increasing their positions, 81 reducing their positions, and 23 closing their positions.
39% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 23
21% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 81
10% more capital invested
Capital invested by funds: $2.76B → $3.03B (+$269M)
6.64% more ownership
Funds ownership: 92.39% → 99.02% (+6.6%)
2% more funds holding
Funds holding: 233 → 238 (+5)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
79% less call options, than puts
Call options by funds: $1.85M | Put options by funds: $8.65M
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$36.2M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$33.4M |
| 3 |
BlackRock
New York
|
+$31.5M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$21.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.2M |
Top Sellers
HQY Hedge Fund Activity: Q3 2017 in Review
238 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q3 2017, worth a combined $3.03B — up 9.7% from $2.76B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new HQY positions and 23 closed out — a net gain of 9 holders — while 98 added to existing stakes and 81 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $36.2M. The largest seller was W.R. Berkley Corp, cutting an estimated $25M.
- 238 institutional investors held HealthEquity (HQY) as of Q3 2017, up from 233 in Q2 2017.
- Funds reported $3.03B of HealthEquity stock for Q3 2017, up 9.7% quarter-over-quarter.
- 32 funds opened new HealthEquity positions in Q3 2017 and 23 closed out, a net change of +9 holders.
- The largest HealthEquity buyer in Q3 2017 was Royal Bank of Canada, an estimated $36.2M added.
- The largest HealthEquity seller in Q3 2017 was W.R. Berkley Corp, an estimated $25M sold.
Based on aggregated 13F filings for Q3 2017.